Camlin Fine Chemicals has been given the green light from its board of directors to acquire an unnamed Italian fine chemicals manufacturer and form a subsidiary company to help boost its presence in the Middle East.
Johnson & Johnson (J&J) has expanded its US OTC drug recall after revealing that many more products than first thought may be contaminated by the wood dye, 2,4,6-tribromoanisole (TBA).
The Nucleotide Research Complex, the largest such facility in the Middle East, is now operational and ready to house companies’ research and development, analytical, diagnostic and equipment training activities.
A $150m (€100m) biologics manufacturing plant is being setup in Abu Dhabi to produce therapeutics for the Middle East and North Africa, according to the Khaleej Times.
The number of CROs operating in the United Arab Emirates (UAE) is set to rise, according to an expert on the region, as companies are attracted by the cost effectiveness and presence of big pharma.
The United Arab Emirates (UAE) is looking to establish itself as a prime location for pharmaceutical companies, with “massive amounts of money and huge incentives” being used to attract business.
Bayer Technology Services GmbH, an affiliate of Germany's Bayer, has opened its first regional office in India, enlarging its presence in the fast-growing Asian markets.
A new enterprise in the United Arab Emirates (UAE) is establishing
itself as the region's first pharmaceutical-focused third party
logistics (3PL) provider.
Indian biotech heavyweight Biocon has today announced that its
joint venture with Abu Dhabi-based Neopharma has spawned new
company NeoBiocon, operating out of one of Dubai's newest
biotechnology parks.
Sales, sales, sales has been the focus of drug manufacturers so far
this year, while interest continues to remain high on the topics of
India and generics.
Oman Pharmaceutical Products (OPP) has entered its first
outsourcing partnership in Europe with Finnish company
Dragenopharm, providing the first step in its strategy to offer
contract manufacturing services globally.
Indian companies may be making great strides in capturing
international market shares for bulk pharmaceutical ingredients and
generic drugs, but to date they have not made a great impression on
the laboratory tool market.
Neo Pharma becomes the first company to start manufacturing
pharmaceuticals in Abu Dhabi. The company's facility offers both
production and R&D capabilities.
